1-9 of 9
Francesca Carlomagno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retraction: The Receptor-Type Protein Tyrosine Phosphatase J Antagonizes the Biochemical and Biological Effects of RET-Derived Oncoproteins

Free
Angela Iervolino, Rodolfo Iuliano, Francesco Trapasso, Giuseppe Viglietto, Rosa Marina Melillo, Francesca Carlomagno, Massimo Santoro, Alfredo Fusco
Journal: Cancer Research
Cancer Res (2018) 78 (24): 6907.
https://doi.org/10.1158/0008-5472.CAN-18-3456
Published: 13 December 2018
View articletitled, Retraction: The Receptor-Type Protein Tyrosine Phosphatase J Antagonizes the Biochemical and Biological Effects of RET-Derived Oncoproteins
Open the PDF for Retraction: The Receptor-Type Protein Tyrosine Phosphatase J Antagonizes the Biochemical and Biological Effects of RET-Derived Oncoproteins in another window
Journal Articles

Identification of Polo-like Kinase 1 as a Potential Therapeutic Target in Anaplastic Thyroid Carcinoma

Free
Tito Claudio Nappi, Paolo Salerno, Horst Zitzelsberger, Francesca Carlomagno, Giuliana Salvatore, Massimo Santoro
Journal: Cancer Research
Cancer Res (2009) 69 (5): 1916–1923.
https://doi.org/10.1158/0008-5472.CAN-08-1693
Published: 02 March 2009
View articletitled, Identification of Polo-like Kinase 1 as a Potential Therapeutic Target in Anaplastic Thyroid Carcinoma
Open the PDF for Identification of Polo-like Kinase 1 as a Potential Therapeutic Target in Anaplastic Thyroid Carcinoma in another window
Includes: Supplementary data
Journal Articles

The Receptor-Type Protein Tyrosine Phosphatase J Antagonizes the Biochemical and Biological Effects of RET-Derived Oncoproteins

Free
Angela Iervolino, Rodolfo Iuliano, Francesco Trapasso, Giuseppe Viglietto, Rosa Marina Melillo, Francesca Carlomagno, Massimo Santoro, Alfredo Fusco
Journal: Cancer Research
Cancer Res (2006) 66 (12): 6280–6287.
https://doi.org/10.1158/0008-5472.CAN-06-0228
Published: 15 June 2006
View articletitled, The Receptor-Type Protein Tyrosine Phosphatase J Antagonizes the Biochemical and Biological Effects of RET-Derived Oncoproteins
Open the PDF for The Receptor-Type Protein Tyrosine Phosphatase J Antagonizes the Biochemical and Biological Effects of RET-Derived Oncoproteins in another window
Journal Articles

Regulation of p27Kip1 Protein Levels Contributes to Mitogenic Effects of the RET/PTC Kinase in Thyroid Carcinoma Cells

Free
Donata Vitagliano, Francesca Carlomagno, Maria Letizia Motti, Giuseppe Viglietto, Yuri E. Nikiforov, Marina N. Nikiforova, Jerome M. Hershman, Anderson J. Ryan, Alfredo Fusco, Rosa Marina Melillo, Massimo Santoro
Journal: Cancer Research
Cancer Res (2004) 64 (11): 3823–3829.
https://doi.org/10.1158/0008-5472.CAN-03-3918
Published: 01 June 2004
View articletitled, Regulation of p27Kip1 Protein Levels Contributes to Mitogenic Effects of the RET/PTC Kinase in Thyroid Carcinoma Cells
Open the PDF for Regulation of p27Kip1 Protein Levels Contributes to Mitogenic Effects of the RET/PTC Kinase in Thyroid Carcinoma Cells in another window
Journal Articles

ZD6474, an Orally Available Inhibitor of KDR Tyrosine Kinase Activity, Efficiently Blocks Oncogenic RET Kinases

Free
Francesca Carlomagno, Donata Vitagliano, Teresa Guida, Fortunato Ciardiello, Giampaolo Tortora, Giancarlo Vecchio, Anderson J. Ryan, Gabriella Fontanini, Alfredo Fusco, Massimo Santoro
Journal: Cancer Research
Cancer Res (2002) 62 (24): 7284–7290.
Published: 15 December 2002
View articletitled, ZD6474, an Orally Available Inhibitor of KDR Tyrosine Kinase Activity, Efficiently Blocks Oncogenic RET Kinases
Open the PDF for ZD6474, an Orally Available Inhibitor of KDR Tyrosine Kinase Activity, Efficiently Blocks Oncogenic RET Kinases in another window
Journal Articles

The Kinase Inhibitor PP1 Blocks Tumorigenesis Induced by RET Oncogenes

Free
Francesca Carlomagno, Donata Vitagliano, Teresa Guida, Maria Napolitano, Giancarlo Vecchio, Alfredo Fusco, Aviv Gazit, Alexander Levitzki, Massimo Santoro
Journal: Cancer Research
Cancer Res (2002) 62 (4): 1077–1082.
Published: 01 February 2002
View articletitled, The Kinase Inhibitor PP1 Blocks Tumorigenesis Induced by RET Oncogenes
Open the PDF for The Kinase Inhibitor PP1 Blocks Tumorigenesis Induced by RET Oncogenes in another window
Journal Articles

Tyrosine 1062 of RET-MEN2A Mediates Activation of Akt (Protein Kinase B) and Mitogen-activated Protein Kinase Pathways Leading to PC12 Cell Survival

Free
Gabriella De Vita, Rosa Marina Melillo, Francesca Carlomagno, Roberta Visconti, Maria Domenica Castellone, Alfonso Bellacosa, Marc Billaud, Alfredo Fusco, Philip N. Tsichlis, Massimo Santoro
Journal: Cancer Research
Cancer Res (2000) 60 (14): 3727–3731.
Published: 15 July 2000
View articletitled, Tyrosine 1062 of RET-MEN2A Mediates Activation of Akt (Protein Kinase B) and Mitogen-activated Protein Kinase Pathways Leading to PC12 Cell Survival
Open the PDF for Tyrosine 1062 of RET-MEN2A Mediates Activation of Akt (Protein Kinase B) and Mitogen-activated Protein Kinase Pathways Leading to PC12 Cell Survival in another window
Journal Articles

Ret-mediated Mitogenesis Requires Src Kinase Activity

Free
Rosa Marina Melillo, Maria Vittoria Barone, Gelsy Lupoli, Anna Maria Cirafici, Francesca Carlomagno, Roberta Visconti, Brona Matoskova, Pier Paolo Di Fiore, Giancarlo Vecchio, Alfredo Fusco, Massimo Santoro
Journal: Cancer Research
Cancer Res (1999) 59 (5): 1120–1126.
Published: 01 March 1999
View articletitled, Ret-mediated Mitogenesis Requires Src Kinase Activity
Open the PDF for Ret-mediated Mitogenesis Requires Src Kinase Activity in another window
Journal Articles

The Different RET-activating Capability of Mutations of Cysteine 620 or Cysteine 634 Correlates with the Multiple Endocrine Neoplasia Type 2 Disease Phenotype

Free
Francesca Carlomagno, Giuliana Salvatore, Anna Maria Cirafici, Gabriella De Vita, Rosa Marina Melillo, Vittorio de Franciscis, Marc Billaud, Alfredo Fusco, Massimo Santoro
Journal: Cancer Research
Cancer Res (1997) 57 (3): 391–395.
Published: 01 February 1997
View articletitled, The Different RET-activating Capability of Mutations of Cysteine 620 or Cysteine 634 Correlates with the Multiple Endocrine Neoplasia Type 2 Disease Phenotype
Open the PDF for The Different RET-activating Capability of Mutations of Cysteine 620 or Cysteine 634 Correlates with the Multiple Endocrine Neoplasia Type 2 Disease Phenotype in another window